Related Experiment Video

Updated: Apr 5, 2026

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

8.1K

[BREAST CANCER: FROM TARGETED THERAPY TO PRECISION MEDICINE]

G Jerusalem, J Collignon, Cl Josse

    Revue Medicale De Liege
    |August 20, 2015
    PubMed

    Insights

    This review explores systemic therapy for breast cancer, highlighting how genomic data can personalize treatment. Challenges remain in applying this precision medicine approach due to rare alterations and tumor heterogeneity.

    Area of Science:

    • Oncology
    • Genomics
    • Pharmacology

    Background:

    • Systemic therapy is a cornerstone of breast cancer treatment.
    • Current treatment strategies aim for individualization based on patient and tumor characteristics.

    Purpose of the Study:

    • To review the principles of systemic therapy in breast cancer.
    • To analyze the extent of treatment individualization in current practice.
    • To discuss the integration of genomic data into clinical decision-making.

    Main Methods:

    • Literature review of systemic therapy principles in breast cancer.
    • Analysis of current treatment individualization strategies.
    • Discussion of emerging technologies for genomic alteration detection.

    Main Results:

    • New technologies enable the detection of genomic alterations in cancer cells.
    • Significant challenges exist in utilizing genomic knowledge for routine patient care.
    • The rarity of most genomic alterations complicates drug development.

    Conclusions:

    • Tumor heterogeneity (temporal and spatial) must be considered for effective treatment.
    • International collaboration is crucial to validate the benefits of precision medicine in improving breast cancer outcomes.

    More Related Videos

    Automating Tumor Implantation in Zebrafish Larvae for Cancer Research and Medicine06:14

    Automating Tumor Implantation in Zebrafish Larvae for Cancer Research and Medicine

    Published on: September 19, 2025

    1.2K
    Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?14:20

    Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

    Published on: June 13, 2014

    17.2K

    Related Concept Videos

    Targeted Cancer Therapies02:57

    Targeted Cancer Therapies

    The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
    There are several types of targeted therapies against...
    9.1K
    Targeted Cancer Therapies02:57

    Targeted Cancer Therapies

    1.8K
    Combination Therapies and Personalized Medicine02:50

    Combination Therapies and Personalized Medicine

    Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
    The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
    6.3K
    Combination Therapies and Personalized Medicine02:50

    Combination Therapies and Personalized Medicine

    1.8K
    Pharmacogenomics: Identification of New Drug Targets01:29

    Pharmacogenomics: Identification of New Drug Targets

    Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
    86
    Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

    Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

    Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
    69